Dr. Ole F. Olesen is the Executive Director of the European Vaccine Initiative (EVI). He has studied at the universities of Aarhus, Denmark, and Cambridge, UK, as well as at Copenhagen Business School, and he holds a PhD degree in Molecular Biology and an HD degree in international economics. He has worked for 10 years in the pharmaceutical industry as a group leader and as a Global Project Director for the pre-clinical and clinical development of vaccines and injectables. He has considerable work experience in conducting and managing large international projects on pharmaceutical product development in Europe, Africa, and Asia. Before joining EVI, he was Director of International Cooperation at the European & Developing Countries Clinical Trials Partnership (EDCTP) from 2013 to 2019, a position he took on after that of Principal Scientific Officer for infectious diseases at the European Commission's Directorate-General for Research & Innovation. He is a Fellow of the Royal College of Physicians in Edinburg and also holds a position as an affiliated professor in global health at Copenhagen University.
Dr. Ole F. Olesen is the Executive Director of the European Vaccine Initiative (EVI). He has studied at the universities of Aarhus, Denmark, and Cambridge, UK, as well as at Copenhagen Business School, and he holds a PhD degree in Molecular Biology and an HD degree in international economics. He has worked for 10 years in the pharmaceutical industry as a group leader and as a Global Project Director for the pre-clinical and clinical development of vaccines and injectables. He has considerable work experience in conducting and managing large international projects on pharmaceutical product development in Europe, Africa, and Asia. Before joining EVI, he was Director of International Cooperation at the European & Developing Countries Clinical Trials Partnership (EDCTP) from 2013 to 2019, a position he took on after that of Principal Scientific Officer for infectious diseases at the European Commission's Directorate-General for Research & Innovation. He is a Fellow of the Royal College of Physicians in Edinburg and also holds a position as an affiliated professor in global health at Copenhagen University.